These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 26735004)
1. Retention, dosing, tolerability and patient reported seizure outcome of Zonisamide as only add-on treatment under real-life conditions in adult patients with partial onset seizures: Results of the observational study ZOOM. Hamer H; Baulac M; McMurray R; Kockelmann E Seizure; 2016 Jan; 34():66-73. PubMed ID: 26735004 [TBL] [Abstract][Full Text] [Related]
2. [Anticonvulsant add-on therapy with Eslicarbazepine acetate : Results of the EPOS-study in adults in Germany]. Losch FP; Holtkamp M; McMurray R; Lendemans D; Kockelmann E Nervenarzt; 2016 Oct; 87(10):1094-1099. PubMed ID: 27550387 [TBL] [Abstract][Full Text] [Related]
3. Management and monitoring of patients treated with zonisamide: the OZONE study. Dupont S; Biraben A; Lavernhe G; Marquet T; Allaf B Epileptic Disord; 2013 Sep; 15(3):278-88. PubMed ID: 23906691 [TBL] [Abstract][Full Text] [Related]
4. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. Shinnar S; Pellock JM; Conry JA Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174 [TBL] [Abstract][Full Text] [Related]
5. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study. Baulac M; Patten A; Giorgi L Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239 [TBL] [Abstract][Full Text] [Related]
6. [The role of zonisamide in the management of pediatric partial epilepsy]. Rosdy B; Kollár K; Móser J; Mellár M Ideggyogy Sz; 2016 Jul; 69(7-8):233-237. PubMed ID: 29465887 [TBL] [Abstract][Full Text] [Related]
7. Zonisamide in the management of epilepsy--Japanese experience. Ohtahara S Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507 [TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of zonisamide in paediatric patients with epilepsy. Cross JH; Auvin S; Patten A; Giorgi L Eur J Paediatr Neurol; 2014 Nov; 18(6):747-58. PubMed ID: 25128350 [TBL] [Abstract][Full Text] [Related]
9. Zonisamide monotherapy for epilepsy in children and young adults. Wilfong AA Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures. Baulac M; Leppik IE Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670 [TBL] [Abstract][Full Text] [Related]
11. Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: a multicenter open-label single-arm trial in Korean patients. Heo K; Lee BI; Yi SD; Cho YW; Shin DJ; Song HK; Kim OJ; Park SP; Kim SE; Kim SH; Lee JH; Kim KS; Lee SJ Seizure; 2012 Apr; 21(3):188-93. PubMed ID: 22226572 [TBL] [Abstract][Full Text] [Related]
12. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial. Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953 [TBL] [Abstract][Full Text] [Related]
13. Flexible dosing of adjunctive zonisamide in the treatment of adult partial-onset seizures: a non-comparative, open-label study (ZEUS). Dupont S; Striano S; Trinka E; Springub J; Giallonardo AT; Smith P; Ellis S; Yeates A; Baker G Acta Neurol Scand; 2010 Mar; 121(3):141-8. PubMed ID: 20047564 [TBL] [Abstract][Full Text] [Related]
14. Zonisamide: its pharmacology, efficacy and safety in clinical trials. Brodie MJ; Ben-Menachem E; Chouette I; Giorgi L Acta Neurol Scand Suppl; 2012; (194):19-28. PubMed ID: 23106522 [TBL] [Abstract][Full Text] [Related]
15. A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy. Guerrini R; Rosati A; Segieth J; Pellacani S; Bradshaw K; Giorgi L Epilepsia; 2013 Aug; 54(8):1473-80. PubMed ID: 23837461 [TBL] [Abstract][Full Text] [Related]
16. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study. Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971 [TBL] [Abstract][Full Text] [Related]
17. Long-term retention rate of zonisamide in patients with epilepsy: an observational study. Kim DW; Choi K; Moon HS; Oh J Clin Neuropharmacol; 2014; 37(5):133-5. PubMed ID: 25229169 [TBL] [Abstract][Full Text] [Related]
18. Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital. Hasegawa H Curr Med Res Opin; 2004 May; 20(5):577-80. PubMed ID: 15140322 [TBL] [Abstract][Full Text] [Related]
19. Real-world data on eslicarbazepine acetate as add-on to antiepileptic monotherapy. Holtkamp M; McMurray R; Bagul M; Sousa R; Kockelmann E Acta Neurol Scand; 2016 Jul; 134(1):76-82. PubMed ID: 26915469 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness and tolerability of adjunctive brivaracetam in patients with focal seizures: Second interim analysis of 6-month data from a prospective observational study in Europe. Steinhoff BJ; Christensen J; Doherty CP; Majoie M; De Backer M; Hellot S; Leunikava I; Leach JP Epilepsy Res; 2020 Sep; 165():106329. PubMed ID: 32623096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]